Lebrun A - Search Results

1

Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon.

Barkhouse DA, Garcia SA, Bongiorno EK, Lebrun A, Faber M, Hooper DC. Barkhouse DA, et al. Among authors: lebrun a. J Virol. 2015 Jan;89(1):312-22. doi: 10.1128/JVI.01572-14. Epub 2014 Oct 15. J Virol. 2015. PMID: 25320312 Free PMC article.

2

T-bet Is Required for the Rapid Clearance of Attenuated Rabies Virus from Central Nervous System Tissue.

Lebrun A, Portocarrero C, Kean RB, Barkhouse DA, Faber M, Hooper DC. Lebrun A, et al. J Immunol. 2015 Nov 1;195(9):4358-68. doi: 10.4049/jimmunol.1501274. Epub 2015 Sep 25. J Immunol. 2015. PMID: 26408670 Free PMC article.

3

Brain tissue-resident immune memory cells are required for long-term protection against CNS infection with rabies virus.

Lebrun A, Kean RB, Hooper DC. Lebrun A, et al. Future Virol. 2020 Nov;15(11):755-761. doi: 10.2217/fvl-2020-0132. Epub 2020 Dec 8. Future Virol. 2020. PMID: 33343683 Free PMC article. Review.

4

Clearance of attenuated rabies virus from brain tissues is required for long-term protection against CNS challenge with a pathogenic variant.

Garcia SA, Lebrun A, Kean RB, Craig Hooper D. Garcia SA, et al. Among authors: lebrun a. J Neurovirol. 2018 Oct;24(5):606-615. doi: 10.1007/s13365-018-0655-z. Epub 2018 Jul 9. J Neurovirol. 2018. PMID: 29987584 Free PMC article.

5

Protection Against CNS-Targeted Rabies Virus Infection is Dependent upon Type-1 Immune Mechanisms Induced by Live-Attenuated Rabies Vaccines.

Lebrun A, Garcia S, Li J, Kean RB, Hooper DC. Lebrun A, et al. Trop Med Infect Dis. 2017 Jul 4;2(3):22. doi: 10.3390/tropicalmed2030022. Trop Med Infect Dis. 2017. PMID: 30270881 Free PMC article.

6

Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells.

Palmieri EM, Menga A, Lebrun A, Hooper DC, Butterfield DA, Mazzone M, Castegna A. Palmieri EM, et al. Among authors: lebrun a. Antioxid Redox Signal. 2017 Mar 10;26(8):351-363. doi: 10.1089/ars.2016.6715. Epub 2016 Nov 2. Antioxid Redox Signal. 2017. PMID: 27758118 Free PMC article.

7

Systemic Immune Bias Delineates Malignant Astrocytoma Survival Cohorts.

Prosniak M, Harshyne LA, Gorky J, Curtis MT, Kenyon LC, Schwaber JS, Lebrun A, Kean RB, Andrews DW, Hooper DC. Prosniak M, et al. Among authors: lebrun a. J Immunol. 2021 Apr 1;206(7):1483-1492. doi: 10.4049/jimmunol.2000901. Epub 2021 Mar 8. J Immunol. 2021. PMID: 33685995

8

Sphenopalatine ganglion stimulation is a reversible and frequency-dependent modulator of the blood-brain barrier.

Schmidt RF, Theofanis TN, Lang MJ, Stricsek GP, Lin R, Lebrun A, Hooper DC, Rosenwasser RH, Sharan AD, Iacovitti L. Schmidt RF, et al. Among authors: lebrun a. Brain Res. 2019 Sep 1;1718:231-241. doi: 10.1016/j.brainres.2019.04.030. Epub 2019 Apr 26. Brain Res. 2019. PMID: 31034813

9

Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy.

Rigau V, Morin M, Rousset MC, de Bock F, Lebrun A, Coubes P, Picot MC, Baldy-Moulinier M, Bockaert J, Crespel A, Lerner-Natoli M. Rigau V, et al. Among authors: lebrun a. Brain. 2007 Jul;130(Pt 7):1942-56. doi: 10.1093/brain/awm118. Epub 2007 May 28. Brain. 2007. PMID: 17533168

10

IgG leakage may contribute to neuronal dysfunction in drug-refractory epilepsies with blood-brain barrier disruption.

Michalak Z, Lebrun A, Di Miceli M, Rousset MC, Crespel A, Coubes P, Henshall DC, Lerner-Natoli M, Rigau V. Michalak Z, et al. Among authors: lebrun a. J Neuropathol Exp Neurol. 2012 Sep;71(9):826-38. doi: 10.1097/NEN.0b013e31826809a6. J Neuropathol Exp Neurol. 2012. PMID: 22878666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters